Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Patents, commons, and innovation in psychedelic drug development


Patents, commons, and innovation in psychedelic drug development

As universities and companies stake intellectual property claims on psychedelic compounds, applications, and data sets, a robust dialogue has emerged about the way patents and data exclusivity may accelerate or constrain innovation, competition, and access to care. Join us for a nuanced consideration of the economic and cultural implications of intellectual property rights within the psychedelic ecosystem.

Share: Patents, commons, and innovation in psychedelic drug development


Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.

Report an Error

The PS2023: The Virtual Trip team has worked hard to create session captions, transcripts, and web pages as accurately as possible, but we know that some errors may have made it past our review process. Let us know what needs to be fixed! Please provide the session name and/or page URL where you found the error, the time the error occurs (if in a video), and the correct information we should use to fix the error. We appreciate your help in making PS2023: The Virtual Trip even better!

This field is for validation purposes and should be left unchanged.